Since the 2011 FDA approval of the first checkpoint inhibitor, ipilimumab, immuno-oncology has gained momentum as a premier therapeutic strategy within precision medicine. Its promise is evident: the ...

New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare's immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers ...

Agilent a global leader in life science, diagnostics, and analytical laboratory technologies, is pleased to announce the Immuno-Oncology & Cancer Biology Virtual Conference on July 29, 2020. This live ...

Labroots is pleased to announce the 5th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking research in ...

TINLEY PARK, Illinois, March 12, 2019 /PRNewswire/ -- Hematogenix®- a global leader in the field of integrated pathology services for drug development and immuno-oncology testing, today announced the ...